IMVT icon

Immunovant
IMVT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$40
35% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
33% 1-yr IMVT win rate
10 Feb ‘26 2 months ago
Guggenheim
Guggenheim
Yatin Suneja
50% 1-yr IMVT win rate
9 Feb ‘26 2 months ago